318 related articles for article (PubMed ID: 16259110)
1. Expression of CDX2 and MUC2 in Barrett's mucosa.
Steininger H; Pfofe DA; Müller H; Haag-Sunjic G; Fratianu V
Pathol Res Pract; 2005; 201(8-9):573-7. PubMed ID: 16259110
[TBL] [Abstract][Full Text] [Related]
2. CDX2, COX2 and MUC2 expressions in Barrett's esophagus: can they be useful in determination of the dysplasia?
Türkmen IÇ; Başsüllü N; Uraz S; Yerdel MA; Memışoğlu R; Bülbül Doğusoy G
Turk Patoloji Derg; 2012; 28(3):251-8. PubMed ID: 23011828
[TBL] [Abstract][Full Text] [Related]
3. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.
Phillips RW; Frierson HF; Moskaluk CA
Am J Surg Pathol; 2003 Nov; 27(11):1442-7. PubMed ID: 14576477
[TBL] [Abstract][Full Text] [Related]
4. Expression of mucin-2 and correlation with PAS-alcian blue stain in Barrett's esophagus.
Lopes CV; Pereira-Lima J; Hartmann A
Hepatogastroenterology; 2006; 53(70):511-5. PubMed ID: 16995451
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa.
Eda A; Osawa H; Satoh K; Yanaka I; Kihira K; Ishino Y; Mutoh H; Sugano K
J Gastroenterol; 2003; 38(1):14-22. PubMed ID: 12560917
[TBL] [Abstract][Full Text] [Related]
6. Does CDX2 expression predict Barrett's metaplasia in oesophageal columnar epithelium without goblet cells?
Kerkhof M; Bax DA; Moons LM; van Vuuren AJ; van Dekken H; Steyerberg EW; Kuipers EJ; Kusters JG; Siersema PD;
Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1613-21. PubMed ID: 17206949
[TBL] [Abstract][Full Text] [Related]
7. Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett's) metaplasia.
Groisman GM; Amar M; Meir A
Mod Pathol; 2004 Oct; 17(10):1282-8. PubMed ID: 15167938
[TBL] [Abstract][Full Text] [Related]
8. CDX2 protein expression compared to alcian blue staining in the evaluation of esophageal intestinal metaplasia.
Johnson DR; Abdelbaqui M; Tahmasbi M; Mayer Z; Lee HW; Malafa MP; Coppola D
World J Gastroenterol; 2015 Mar; 21(9):2770-6. PubMed ID: 25759548
[TBL] [Abstract][Full Text] [Related]
9. The homeodomain protein CDX2 is an early marker of Barrett's oesophagus.
Moons LM; Bax DA; Kuipers EJ; Van Dekken H; Haringsma J; Van Vliet AH; Siersema PD; Kusters JG
J Clin Pathol; 2004 Oct; 57(10):1063-8. PubMed ID: 15452161
[TBL] [Abstract][Full Text] [Related]
10. Notch signaling pathway and Cdx2 expression in the development of Barrett's esophagus.
Tamagawa Y; Ishimura N; Uno G; Yuki T; Kazumori H; Ishihara S; Amano Y; Kinoshita Y
Lab Invest; 2012 Jun; 92(6):896-909. PubMed ID: 22449796
[TBL] [Abstract][Full Text] [Related]
11. CDX2 and LI-cadherin expression in esophageal mucosa: use of both markers can facilitate the histologic diagnosis of Barrett's esophagus and carcinoma.
Weimann A; Zimmermann M; Gross M; Slevogt H; Rieger A; Morawietz L
Int J Surg Pathol; 2010 Oct; 18(5):330-7. PubMed ID: 20444732
[TBL] [Abstract][Full Text] [Related]
12. [Histochemical diagnosis of short segment Barrett's esophagus].
Fujiyama Y; Ishizuka I; Koyama S
Nihon Rinsho; 2005 Aug; 63(8):1420-6. PubMed ID: 16101233
[TBL] [Abstract][Full Text] [Related]
13. Immunoreactivity of cytokeratins 7 and 20 in goblet cells and columnar blue cells in patients with endoscopic evidence of Barrett's esophagus.
Cantarelli JC; Fagundes RB; Meurer L; Rocha MP; Nicola A; Kruel CD
Arq Gastroenterol; 2009; 46(2):127-31. PubMed ID: 19578614
[TBL] [Abstract][Full Text] [Related]
14. CDX2 expression in columnar metaplasia of the remnant esophagus in patients who underwent esophagectomy.
Bax D; Siersema PD; Moons LM; Dekken Hv; Tilanus HW; Kusters JG; Kuipers EJ
J Clin Gastroenterol; 2007 Apr; 41(4):375-9. PubMed ID: 17413605
[TBL] [Abstract][Full Text] [Related]
15. Pediatric columnar lined esophagus vs Barrett's esophagus: is it the time for a consensus definition.
Cohen MC; Ashok D; Gell M; Bishop J; Walker J; Thomson M; Al-Adnani M
Pediatr Dev Pathol; 2009; 12(2):116-26. PubMed ID: 18684017
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic versus histological diagnosis of Barrett's esophagus: a cross-sectional survey.
Irvanloo G; Fallahi B; Ensani F; Azmi M; Morteza A
Pol J Pathol; 2011 Sep; 62(3):152-6. PubMed ID: 22102072
[TBL] [Abstract][Full Text] [Related]
17. Expression of resistin-like molecule beta in Barrett's esophagus: a novel biomarker for metaplastic epithelium.
Zheng L; Tong Q; Weng M; He J; Lv Q; Wu Z; Du Z; Mei H; Hou X
Dig Dis Sci; 2010 Jan; 55(1):32-9. PubMed ID: 19225886
[TBL] [Abstract][Full Text] [Related]
18. Expression of SOX9 and CDX2 in nongoblet columnar-lined esophagus predicts the detection of Barrett's esophagus during follow-up.
Zhang X; Westerhoff M; Hart J
Mod Pathol; 2015 May; 28(5):654-61. PubMed ID: 25412842
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Barrett's esophagus with CK7, CK20, p53, Ki67, and COX2 expressions using chromoendoscopical examination.
Çoban Ş; Örmeci N; Savaş B; Ekiz F; Ensari A; Kuzu I; Palabıyıkoğlu M
Dis Esophagus; 2013; 26(2):189-96. PubMed ID: 22591041
[TBL] [Abstract][Full Text] [Related]
20. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma.
Yamamoto S; Kijima H; Hara T; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
Int J Mol Med; 2005 Sep; 16(3):375-80. PubMed ID: 16077942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]